Evidence map›Paper›PMID 41168570›Full record

ReviewDiscover mental health2025

Psychiatric comorbidities in HIV/AIDS patients and its overlap with neurological disorders.

Boluwatife Samuel Fatokun, Olivier Uwishema, Nadine Mugisha, Bashirat Oluwatomi Abdulraheem, Claudia Valeria Rivera-Cazaño, Uwineza Jeanne d'Arc, Hillani Tadesse Bekele

Abstract readReview
In one paragraph

Review in Discover mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Boluwatife Samuel FatokunDepartment of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda.
Olivier UwishemaDepartment of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda. uwolivier1@gmail.com.ORCID https://orcid.org/0000-0002-0692-9027
Nadine MugishaDepartment of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda.
Bashirat Oluwatomi AbdulraheemDepartment of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda.
Claudia Valeria Rivera-CazañoDepartment of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda.
Uwineza Jeanne d'ArcDepartment of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda.
Hillani Tadesse BekeleDepartment of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of psychiatric and neurological disorders in populations with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) presents significant public health concerns including impaired quality of life, reduced antiretroviral therapy (ART) adherence, and elevated morbidity and mortality rates. Research suggests that these correlations translate to millions of people globally, given that over 25 million people are living with HIV/AIDS in the African region alone.

objectiveThis article explores the overlap in clinical presentation and pathophysiology between psychiatric and neurological conditions and seeks to fill current knowledge gaps regarding their co-occurrence, misdiagnosis, and impact on treatment outcomes.

methodsA comprehensive literature review was conducted employing electronic search databases comprising PubMed/MEDLINE, ResearchGate, and related databases, using keywords such as “psychiatric disorders,” “neurological disorders,” “HIV,” “AIDS,” and “comorbidities”. Studies were selected based on relevance to the overlap of psychiatric and neurological conditions in HIV/AIDS.

resultsNeurological disorders like HIV-Associated Neurocognitive Disorders (HAND) were observed in 20–50% of HIV/AIDS patients. Similarly, the prevalence of psychiatric symptoms, such as depression and anxiety, among HIV/AIDS patients was reported at 32.9% and 27.4% respectively. Also, overlapping pathophysiological processes, such as neuroinflammation, immune dysregulation, and HIV-related neurotoxicity, were identified as common mechanisms underpinning both psychiatric and neurological disorders in HIV/AIDS patients.

conclusionMultidisciplinary collaborations are warranted to create tailored antiretroviral therapy regimens that minimize neurotoxicity and further investigate the neuropsychiatric overlap to enhance diagnostic accuracy and patient outcomes.

Indexed as

AIDSAntiretroviral therapyHIVNeurological disordersPsychiatric comorbidities

Identifiers

PMID41168570
PMCPMC12575917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.